Abstract:Yalan Luo, 1– 3, &ast Peng Ge, 1– 3, &ast Haiyun Wen, 1– 3, &ast Yibo Zhang, 1– 3 Jin Liu, 1, 3 Xuanchi Dong, 1, 3 Bowen Lan, 1, 3 Guixin Zhang, 1– 3 Qi Yang, 4 Hailong Chen 1– 3 1 Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China; 2 Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, People's Republic of China; 3 Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China; 4 Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qi Yang; Hailong Chen, Email ; Objective: C/EBPβ, a crucial transcription factor, regulates innate immunity and inflammatory responses. However, the role played by C/EBPβ in alveolar macrophage (AM) inflammatory responses remains unknown. This study aimed to investigate the role and mechanism of C/EBPβ in alveolar macrophages (AMs) from the transcriptional level and to search for natural compounds targeting C/EBPβ. Methods: Rat AMs were infected with Lv-sh-C/EBPβ and treated with LPS, and the expression levels of iNOS, TNF-α, IL-6, and IL-1β were measured by RT-qPCR, Western blotting, and ELISA. Mechanistically, transcriptome sequencing (RNA-seq) revealed changes in gene expression patterns in AMs after LPS stimulation and C/EBPβ knockdown. Functional enrichment analyses and rescue experiments identified and validated inflammation-associated cell signaling pathways regulated by C/EBPβ. Furthermore, virtual screening was used to search for natural compounds that inhibit C/EBPβ with the structure of helenalin as a reference. Results: Following stimulation with LPS, AMs exhibited an increased expression of C/EBPβ. C/EBPβ knockdown significantly decreased the expression levels of inflammatory mediators. A total of 374 differentially expressed genes (DEGs) were identified between LPS-stimulated C/EBPβ knockdown and negative control cells. The NOD-like receptor signaling may be a key target for C/EBPβ, according to functional enrichment analyses of the DEGs. Further experiments showed that the muramyl dipeptide (MDP, NOD2 agonist) reversed the downregulation of inflammatory mediators and the NF-κB pathway caused by the C/EBPβ knockdown. The virtual screening revealed that N-caffeoyltryptophan, orilotimod, and petasiphenone have comparable pharmacological properties to helenalin (a known C/EBPβ inhibitor) and demonstrate a great binding capacity to C/EBPβ. Conclusion: Ablation of C/EBPβ may attenuate LPS-induced inflammatory damage in AMs by inhibiting the NOD2 receptor signaling pathway. Three natural compounds, N-caffeoyltryptophan, orilotimod, and petasiphenone, may be potential C/EBPβ inhibitors. Graphical Keywords: C/EBPβ, alveolar macrophage, RNA-seq, NOD-like receptor signaling pathway, IL-1β, virtual screening Graphical Alveolar macrophages (AMs) are alveolar compartment resident phagocytes, constituting more than 90% of lung macrophages, with the ability to self-renew and serve as the first line of defense against extra-alveolar stimuli. 1 Under physiological conditions, AMs play a vital role in maintaining host defense and immune homeostasis in the lung by acting as sentinels to monitor and engulf foreign pathogens and senescent cells. 2 However, in response to stimulation by various pathogenic factors, AMs are excessively activated, which is thought to be the initiating factor of inflammatory damage in the lung. 3 Inflammation induction and recovery phases are accompanied by the explosive accumulation of macrophages in the lungs. They synthesize and secrete a broad series of inflammation-inducing mediators, including the interleukins (ILs) family (IL-1β, IL-12, IL-23), TNF-α, chemokine family, inducible nitric oxide synthase (iNOS), which act as chemoattractants for invading cells (polymorphonuclear leukocytes), triggering an inflammatory cascade and a pro-inflammatory environment, causing inflammatory tissue damage. 4 Inflammatory mediators are effectors and magnifiers of macrophage-induced tissue injury, and inhibiting their expression and secretion is a powerful measure to attenuate organ damage. Unfortunately, transcriptional regulatory networks of inflammatory mediator expression in AMs have not yet been fully elucidated. CCAAT enhancer binding protein β (C/EBPβ) is -Abstract Truncated-

High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors

Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation

Screening of compounds to identify novel epigenetic regulatory factors that affect innate immune memory in macrophages

Computer‐aided discovery of novel aryl hydrocarbon receptor ligands to regulate CYP1A1 expression in inflammatory macrophages

PROTAC‐Mediated HDAC7 Protein Degradation Unveils Its Deacetylase‐Independent Proinflammatory Function in Macrophages

High‐content image‐based screening and deep learning for the detection of anti‐inflammatory drug leads

High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming

Identification and application of anti-inflammatory compounds screening system based on RAW264.7 cells stably expressing NF-κB-dependent SEAP reporter gene

Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors

Preclinical Evaluation of EPHX2 Inhibition As a Novel Treatment for Inflammatory Bowel Disease

C/EBPβ Promotes LPS-Induced IL-1β Transcription and Secretion in Alveolar Macrophages via NOD2 Signaling

A gene expression biomarker identifies inhibitors of two classes of epigenome effectors in a human microarray compendium

Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells

C/EBPβ is a Key Transcription Factor of Ox-Ldl Inducing THP-1 Cells to Release Multiple Pro-Inflammatory Cytokines

A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease

Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties

Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders

Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors

Histone Deacetylase Regulation of MAP Kinase Phosphatase-1 Acetylation and Inflammation (135.36)

A High-Throughput Chemical Screen Identifies Novel Inhibitors and Enhancers of Anti-Inflammatory Functions of the Glucocorticoid Receptor